These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14749172)

  • 21. Iatrogenic hyperammonemia after anorexia.
    Welsh E; Kucera J; Perloff MD
    Arch Intern Med; 2010 Mar; 170(5):486-8. PubMed ID: 20212188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy.
    Howman R; Thakerer A; Pitman M; Ding N; Thompson PA; Khot A; Harrison SJ
    Leuk Lymphoma; 2010 Dec; 51(12):2299-302. PubMed ID: 20929329
    [No Abstract]   [Full Text] [Related]  

  • 23. [Non-secretory primary plasma cell leukemia with hyperammonemia].
    Kawano F; Tsukamoto A; Satoh M; Sanada I; Shido T; Miura K; Murakami T; Kaneko H; Takeya M; Matsuzaki H
    Rinsho Ketsueki; 1991 Apr; 32(4):399-403. PubMed ID: 2067085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic hyperammonemia after high-dose chemotherapy.
    Fine P; Adler K; Gerstenfeld D
    Am J Med; 1989 May; 86(5):629. PubMed ID: 2712077
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperammonemia is associated with generalized convulsion.
    Yanagawa Y; Nishi K; Sakamoto T
    Intern Med; 2008; 47(1):21-3. PubMed ID: 18176000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple myeloma with hyperammonemia].
    Izumi T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):446-8. PubMed ID: 9851186
    [No Abstract]   [Full Text] [Related]  

  • 27. Extensive cortical magnetic resonance signal change in proximal urea cycle disorder.
    Bindu PS; Sinha S; Taly AB; Chandrasekhar HS; Christopher R; Arunodaya GR; Shetty T
    J Child Neurol; 2007 Feb; 22(2):238-9. PubMed ID: 17621492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous double hemodialysis for the control of refractory hyperammonemia.
    Brucculeri M; Gabbard W; Masson J; Jooma N
    Int J Artif Organs; 2013 Feb; 36(2):135-8. PubMed ID: 23404638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].
    Tsunoda S; Sasaki R; Miwa A; Sakurabayashi I; Miura Y
    Rinsho Ketsueki; 1989 Mar; 30(3):361-5. PubMed ID: 2504973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy.
    Schwarz S; Georgiadis D; Schwab S; Gehlen F; Mayatepek E; Zoubaa S
    J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):90-1. PubMed ID: 12082063
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia].
    Kozuka T; Fukuda S; Imai T; Sezaki T
    Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure.
    Kumar R; Shalimar ; Sharma H; Prakash S; Panda SK; Khanal S; Acharya SK
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):925-31. PubMed ID: 22521861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperammonemia-induced encephalopathy due to ornithine transcarbamylase deficiency in an adult woman: identification of novel missense mutations.
    Tanaka A; Wada T; Maruyama M; Tanaka A; Takikawa H; Komatsu Y
    J Gastroenterol; 2005 Jan; 40(1):106-7. PubMed ID: 15692798
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of valproate-induced encephalopathy.
    Hong L; Schutz J; Nance M
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyperammonemic encephalopathy as the presenting feature of multiple myeloma].
    Fernández-Álvarez R; González-García E; Fernández-Álvarez C
    Med Clin (Barc); 2016 Nov; 147(10):472-473. PubMed ID: 27567337
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperammonemia in Urinary Tract Infections.
    Kenzaka T; Kato K; Kitao A; Kosami K; Minami K; Yahata S; Fukui M; Okayama M
    PLoS One; 2015; 10(8):e0136220. PubMed ID: 26292215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperammonemic encephalopathy.
    Brusilow SW
    Medicine (Baltimore); 2002 May; 81(3):240-9. PubMed ID: 11997720
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical manifestation of severe hyperammonaemia in patients with multiple myeloma.
    Martinelli G; Peccatori F; Ullrich B; Ghielmini M; Roggero E; Goldhirsch A
    Ann Oncol; 1997 Aug; 8(8):811. PubMed ID: 9332693
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperammonemia, bane of the brain.
    Cohn RM; Roth KS
    Clin Pediatr (Phila); 2004 Oct; 43(8):683-9. PubMed ID: 15494874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia.
    Matsuzaki H; Matsuno F; Yoshida M; Hata H; Okazaki K; Takatsuki K
    Intern Med; 1992 Mar; 31(3):339-43. PubMed ID: 1611184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.